Latest News and Press Releases
Want to stay updated on the latest news?
-
- Phase 1 study and Investigator Initiated Trial evaluating KL003 for patients with beta thalassemia demonstrated an encouraging efficacy signal and favorable safety profile – - Manufacturing costs...
-
Wilmington, Delaware, United States, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - TMR predicted that the gene vector market is likely to reach US$ 3.4 billion by 2031. Gene...
-
New York, May 19, 2023 (GLOBE NEWSWIRE) -- The global viral vector vaccines market was valued at US$ 738.4 million in 2022 and is projected to expand at a CAGR of 3.9% over the forecast period (2023...